Zimmer Biomet Q1 sales rose 1.1% to $1.91 billion; FY25 EPS outlook trimmed but revenue growth forecast lifted following Paragon 28 acquisition.
Hip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal
Where Today's News Shapes Tomorrow
